Hairy Cell Leukemia Patient Data Registry

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation

Not stated

• Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
• Participants are monitored closely by the research team throughout the study.
• Some participants may receive access to an investigational treatment, which is still being studied.
• Your participation helps researchers learn whether this approach could help future patients.

About this study

The overall objective is to develop a clinical data registry that can be used to facilitate research with the ultimate goal of reducing the morbidity and/or mortality and improving the quality of life of patients diagnosed or living with hairy cell leukemia. With approximately 1,000 new cases of this rare disease identified in the US each year, HCL represents 2% of all cases of leukemia in adults. Considering the rarity of this chronic leukemia, the Hairy Cell Leukemia Foundation (HCLF), in partnership with investigators from its Centers of Excellence, seeks to develop a registry to help researchers identify new trends in outcomes, recognize the most effective treatments, discover previously unknown complications of the disease, and design clinical trials for new therapies.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Study sites (5)